- Filed
- May 3, 2017 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2017 · Apr 26, 2017 | 46.46M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2017 | 62.11M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2016 | 42.54M sh |
| Capex | Q1 2017 · Mar 31, 2017 | $350K |
| Capex | Q1 2017 · Mar 31, 2016 | $735K |
| Cash And Equivalents | Q1 2017 · Mar 31, 2017 | $243.48M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2016 | $198.31M |
| Cash And Equivalents | Q1 2017 · Mar 31, 2016 | $130.08M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2015 | $108.28M |
| Stockholders Equity | Q1 2017 · Mar 31, 2017 | $174.31M |
| Stockholders Equity | Q1 2017 · Dec 31, 2016 | $167.1M |
| Current Liabilities | Q1 2017 · Mar 31, 2017 | $34.83M |
| Current Liabilities | Q1 2017 · Dec 31, 2016 | $32.35M |
| Total Liabilities | Q1 2017 · Mar 31, 2017 | $354.9M |
| Total Liabilities | Q1 2017 · Dec 31, 2016 | $353.75M |
| Current Assets | Q1 2017 · Mar 31, 2017 | $322.36M |
| Current Assets | Q1 2017 · Dec 31, 2016 | $307.23M |
| Total Assets | Q1 2017 · Mar 31, 2017 | $529.2M |
| Total Assets | Q1 2017 · Dec 31, 2016 | $520.85M |
| Eps Diluted | Q1 2017 · Mar 31, 2017 | $0.10 |
| Eps Diluted | Q1 2017 · Mar 31, 2016 | −$0.10 |
| Eps Basic | Q1 2017 · Mar 31, 2017 | $0.11 |
| Eps Basic | Q1 2017 · Mar 31, 2016 | −$0.10 |
| Sga Expense | Q1 2017 · Mar 31, 2017 | $17.69M |
| Sga Expense | Q1 2017 · Mar 31, 2016 | $8.93M |
| Rd Expense | Q1 2017 · Mar 31, 2017 | $10.33M |
| Rd Expense | Q1 2017 · Mar 31, 2016 | $14.67M |
| Net Income | Q1 2017 · Mar 31, 2017 | $4.62M |
| Net Income | Q1 2017 · Mar 31, 2016 | −$4.06M |
| Operating Income | Q1 2017 · Mar 31, 2017 | $10.86M |
| Operating Income | Q1 2017 · Mar 31, 2016 | −$503K |
| Cost Of Revenue | Q1 2017 · Mar 31, 2017 | $16.88M |
| Cost Of Revenue | Q1 2017 · Mar 31, 2016 | $23.34M |
| Revenue | Q1 2017 · Mar 31, 2017 | $56.28M |
| Revenue | Q1 2017 · Mar 31, 2016 | $47.21M |